These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24652699)

  • 1. Investigation of morphometric variability of subthalamic nucleus, red nucleus, and substantia nigra in advanced Parkinson's disease patients using automatic segmentation and PCA-based analysis.
    Xiao Y; Jannin P; D'Albis T; Guizard N; Haegelen C; Lalys F; Vérin M; Collins DL
    Hum Brain Mapp; 2014 Sep; 35(9):4330-44. PubMed ID: 24652699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3T MRI evaluation of the accuracy of atlas-based subthalamic nucleus identification.
    Stancanello J; Muacevic A; Sebastiano F; Modugno N; Cerveri P; Ferrigno G; Uggeri F; Romanelli P
    Med Phys; 2008 Jul; 35(7):3069-77. PubMed ID: 18697530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HybraPD atlas: Towards precise subcortical nuclei segmentation using multimodality medical images in patients with Parkinson disease.
    Yu B; Li L; Guan X; Xu X; Liu X; Yang Q; Wei H; Zuo C; Zhang Y
    Hum Brain Mapp; 2021 Sep; 42(13):4399-4421. PubMed ID: 34101297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patch-based label fusion segmentation of brainstem structures with dual-contrast MRI for Parkinson's disease.
    Xiao Y; Fonov VS; Beriault S; Gerard I; Sadikot AF; Pike GB; Collins DL
    Int J Comput Assist Radiol Surg; 2015 Jul; 10(7):1029-41. PubMed ID: 25249471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging-based morphometry and landmark correlation of basal ganglia nuclei.
    Zhu XL; Hamel W; Schrader B; Weinert D; Hedderich J; Herzog J; Volkmann J; Deuschl G; Müller D; Mehdorn HM
    Acta Neurochir (Wien); 2002 Oct; 144(10):959-69; discussion 968-9. PubMed ID: 12382123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the variability in the anatomical position and size of the subthalamic nucleus among patients with advanced Parkinson's disease using magnetic resonance imaging.
    Daniluk S; G Davies K; Ellias SA; Novak P; Nazzaro JM
    Acta Neurochir (Wien); 2010 Feb; 152(2):201-10; discussion 210. PubMed ID: 19806309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subthalamic and red nucleus volumes in patients with Parkinson's disease: do they change with disease progression?
    Colpan ME; Slavin KV
    Parkinsonism Relat Disord; 2010 Jul; 16(6):398-403. PubMed ID: 20452266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volumetric analysis of the subthalamic and red nuclei based on magnetic resonance imaging in patients with Parkinson's disease.
    Camlidag I; Kocabicak E; Sahin B; Jahanshahi A; Incesu L; Aygun D; Yildiz O; Temel Y; Belet U
    Int J Neurosci; 2014 Apr; 124(4):291-5. PubMed ID: 24020352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substantia Nigra Volume Dissociates Bradykinesia and Rigidity from Tremor in Parkinson's Disease: A 7 Tesla Imaging Study.
    Poston KL; Ua Cruadhlaoich MAI; Santoso LF; Bernstein JD; Liu T; Wang Y; Rutt B; Kerchner GA; Zeineh MM
    J Parkinsons Dis; 2020; 10(2):591-604. PubMed ID: 32250317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated Segmentation and Reconstruction of the Subthalamic Nucleus in Parkinson's Disease Patients.
    Li B; Jiang C; Li L; Zhang J; Meng D
    Neuromodulation; 2016 Jan; 19(1):13-9. PubMed ID: 26484724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seed point discontinuity-based segmentation method for the substantia nigra and the red nucleus in quantitative susceptibility maps.
    Guo T; Song Y; Li J; Fan M; Yan X; He A; Huang D; Shen C; Zhang G; Yang G
    J Magn Reson Imaging; 2018 Oct; 48(4):1112-1119. PubMed ID: 29603826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Automatic Segmentation Algorithms for the Subthalamic Nucleus.
    Polanski WH; Zolal A; Sitoci-Ficici KH; Hiepe P; Schackert G; Sobottka SB
    Stereotact Funct Neurosurg; 2020; 98(4):256-262. PubMed ID: 32369819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T2-relaxometry predicts outcome of DBS in idiopathic Parkinson's disease.
    Lönnfors-Weitzel T; Weitzel T; Slotboom J; Kiefer C; Pollo C; Schüpbach M; Oertel M; Kaelin A; Wiest R
    Neuroimage Clin; 2016; 12():832-837. PubMed ID: 27843765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Most effective stimulation site in subthalamic deep brain stimulation for Parkinson's disease.
    Herzog J; Fietzek U; Hamel W; Morsnowski A; Steigerwald F; Schrader B; Weinert D; Pfister G; Müller D; Mehdorn HM; Deuschl G; Volkmann J
    Mov Disord; 2004 Sep; 19(9):1050-4. PubMed ID: 15372594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting-state functional magnetic resonance imaging of the subthalamic microlesion and stimulation effects in Parkinson's disease: Indications of a principal role of the brainstem.
    Holiga Š; Mueller K; Möller HE; Urgošík D; Růžička E; Schroeter ML; Jech R
    Neuroimage Clin; 2015; 9():264-74. PubMed ID: 26509113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3T MRI-SWI based volumetric analysis of the subthalamic and red nuclei in advanced Parkinson's disease.
    Shah V; Alugolu R; Arora A; Kandadai RM; Mudumba V; Borgohain R
    J Neurosurg Sci; 2023 Feb; 67(1):108-112. PubMed ID: 32401475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct visualization of the human subthalamic nucleus with 3T MR imaging.
    Slavin KV; Thulborn KR; Wess C; Nersesyan H
    AJNR Am J Neuroradiol; 2006 Jan; 27(1):80-4. PubMed ID: 16418362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation.
    Pal GD; Ouyang B; Serrano G; Shill HA; Goetz C; Stebbins G; Metman LV; Driver-Dunckley E; Mehta SH; Caviness JN; Sabbagh MN; Adler CH; Beach TG;
    Mov Disord; 2017 Feb; 32(2):274-277. PubMed ID: 27911008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional MRI is inadequate to delineate the relationship between the red nucleus and subthalamic nucleus in Parkinson's disease.
    Danish SF; Jaggi JL; Moyer JT; Finkel L; Baltuch GH
    Stereotact Funct Neurosurg; 2006; 84(1):12-8. PubMed ID: 16636641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.